Loading company…
Quench Bio, based in Cambridge, Massachusetts, develops molecule drugs and therapies for autoimmune and inflammatory conditions.
Founded in 2018 and based in Massachusetts, US, Quench Bio, Inc. develops molecule drugs and therapies focused on autoimmune and inflammation indications. The company is listed at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in